AbCellera Biologics Company
AbCellera focuses on therapeutic antibodies, screening, choosing, and analyzing millions of naturally produced antibodies to be used as next-generation drug candidates. It specializes in the fields of biotechnology, medicine, and therapeutics.
.png)
.png)
.png)
.png)
Industry:
Early Drug Development
Headquarters:
Vancouver, British Columbia, Canada
Founded Date:
2012-01-01
Employees Number:
101-250
Funding Status:
IPO
Investors Number:
12
Total Funding:
371217878
Estimated Revenue:
$10M to $50M
Last Funding Date:
2020-05-27
Last Funding Type:
Series B
Register and Claim Ownership